Do analysts recommend JYNT or CCRN?

Cross Country Healthcare has a consensus price target of $12.05, indicating a potential downside of 9.06%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cross Country Healthcare 1 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.90

Does the media favor JYNT or CCRN?

In the previous week, Joint had 6 more articles in the media than Cross Country Healthcare. MarketBeat recorded 7 mentions for Joint and 1 mentions for Cross Country Healthcare. Joint's average media sentiment score of 0.66 beat Cross Country Healthcare's score of 0.00 indicating that Joint is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Joint 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer JYNT or VMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Viemed Healthcare 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better valuation & earnings, JYNT or VMD?

Viemed Healthcare has higher revenue and earnings than Joint. Viemed Healthcare is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Joint $58.55M 2.07 $2.91M $0.27 31.48 Viemed Healthcare $270.28M 1.31 $14.93M $0.36 25.83

Does the media prefer JYNT or VMD?

In the previous week, Joint had 3 more articles in the media than Viemed Healthcare. MarketBeat recorded 7 mentions for Joint and 4 mentions for Viemed Healthcare. Joint's average media sentiment score of 0.66 beat Viemed Healthcare's score of 0.16 indicating that Joint is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Joint 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Viemed Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate TACO or JYNT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, TACO or JYNT?

Joint has higher revenue and earnings than Berto Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Joint $58.55M 2.07 $2.91M $0.27 31.48

Do analysts prefer SBC or JYNT?

SBC Medical Group presently has a consensus target price of $8.50, indicating a potential upside of 172.87%. Given SBC Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe SBC Medical Group is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SBC Medical Group 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, SBC or JYNT?

SBC Medical Group has higher revenue and earnings than Joint. SBC Medical Group is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SBC Medical Group $173.61M 1.84 $50.99M $0.39 7.99 Joint $58.55M 2.07 $2.91M $0.27 31.48

Is SBC or JYNT more profitable?

SBC Medical Group has a net margin of 24.09% compared to Joint's net margin of 6.49%. SBC Medical Group's return on equity of 15.90% beat Joint's return on equity. Company Net Margins Return on Equity Return on Assets SBC Medical Group 24.09% 15.90% 11.61% Joint 6.49% 12.02% 3.47%

Does the media prefer SBC or JYNT?

In the previous week, Joint had 6 more articles in the media than SBC Medical Group. MarketBeat recorded 7 mentions for Joint and 1 mentions for SBC Medical Group. Joint's average media sentiment score of 0.66 beat SBC Medical Group's score of 0.00 indicating that Joint is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Joint 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer INFU or JYNT?

InfuSystem currently has a consensus price target of $16.67, suggesting a potential upside of 34.09%. Given InfuSystem's stronger consensus rating and higher possible upside, research analysts clearly believe InfuSystem is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InfuSystem 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, INFU or JYNT?

Joint has lower revenue, but higher earnings than InfuSystem. InfuSystem is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InfuSystem $143.34M 1.75 $870K $0.41 30.31 Joint $58.55M 2.07 $2.91M $0.27 31.48

Is INFU or JYNT more profitable?

Joint has a net margin of 6.49% compared to InfuSystem's net margin of 1.12%. Joint's return on equity of 12.02% beat InfuSystem's return on equity. Company Net Margins Return on Equity Return on Assets InfuSystem 1.12% 2.78% 1.41% Joint 6.49% 12.02% 3.47%

Does the media prefer INFU or JYNT?

In the previous week, Joint had 2 more articles in the media than InfuSystem. MarketBeat recorded 7 mentions for Joint and 5 mentions for InfuSystem. InfuSystem's average media sentiment score of 0.67 beat Joint's score of 0.66 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Joint 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Joint (JYNT) Competitors

$8.51 -0.12 (-1.38%)

As of 12:07 PM Eastern

Compare

JYNT vs. CCRN, VMD, TACO, SBC, and INFU

Should you buy Joint stock or one of its competitors? Joint's main competitors and comparable companies include Cross Country Healthcare (CCRN), Viemed Healthcare (VMD), Berto Acquisition (TACO), SBC Medical Group (SBC), and InfuSystem (INFU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Joint compare to Cross Country Healthcare?

Joint (NASDAQ:JYNT) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Joint has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

76.9% of Joint shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 30.2% of Joint shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Joint has higher earnings, but lower revenue than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint	$58.55M	2.07	$2.91M	$0.27	31.48
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A

In the previous week, Joint had 6 more articles in the media than Cross Country Healthcare. MarketBeat recorded 7 mentions for Joint and 1 mentions for Cross Country Healthcare. Joint's average media sentiment score of 0.66 beat Cross Country Healthcare's score of 0.00 indicating that Joint is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Joint	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cross Country Healthcare has a consensus price target of $12.05, indicating a potential downside of 9.06%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Joint has a net margin of 6.49% compared to Cross Country Healthcare's net margin of -9.84%. Joint's return on equity of 12.02% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Joint	6.49%	12.02%	3.47%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Summary

Joint beats Cross Country Healthcare on 12 of the 15 factors compared between the two stocks.

How does Joint compare to Viemed Healthcare?

Joint (NASDAQ:JYNT) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

In the previous week, Joint had 3 more articles in the media than Viemed Healthcare. MarketBeat recorded 7 mentions for Joint and 4 mentions for Viemed Healthcare. Joint's average media sentiment score of 0.66 beat Viemed Healthcare's score of 0.16 indicating that Joint is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Joint	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Viemed Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Viemed Healthcare	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

76.9% of Joint shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 30.2% of Joint shares are owned by company insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Joint has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

Joint has a net margin of 6.49% compared to Viemed Healthcare's net margin of 4.81%. Joint's return on equity of 12.02% beat Viemed Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Joint	6.49%	12.02%	3.47%
Viemed Healthcare	4.81%	10.16%	7.22%

Viemed Healthcare has higher revenue and earnings than Joint. Viemed Healthcare is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint	$58.55M	2.07	$2.91M	$0.27	31.48
Viemed Healthcare	$270.28M	1.31	$14.93M	$0.36	25.83

Summary

Joint beats Viemed Healthcare on 8 of the 14 factors compared between the two stocks.

How does Joint compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Berto Acquisition has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market. Comparatively, Joint has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

In the previous week, Joint had 7 more articles in the media than Berto Acquisition. MarketBeat recorded 7 mentions for Joint and 0 mentions for Berto Acquisition. Joint's average media sentiment score of 0.66 beat Berto Acquisition's score of 0.00 indicating that Joint is being referred to more favorably in the news media.

Company	Overall Sentiment
Berto Acquisition	Neutral
Joint	Positive

Joint has higher revenue and earnings than Berto Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Joint	$58.55M	2.07	$2.91M	$0.27	31.48

76.9% of Joint shares are held by institutional investors. 30.2% of Joint shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Joint has a net margin of 6.49% compared to Berto Acquisition's net margin of 0.00%. Joint's return on equity of 12.02% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Joint	6.49%	12.02%	3.47%

Summary

Joint beats Berto Acquisition on 10 of the 10 factors compared between the two stocks.

How does Joint compare to SBC Medical Group?

SBC Medical Group (NASDAQ:SBC) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

SBC Medical Group has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Joint has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market.

In the previous week, Joint had 6 more articles in the media than SBC Medical Group. MarketBeat recorded 7 mentions for Joint and 1 mentions for SBC Medical Group. Joint's average media sentiment score of 0.66 beat SBC Medical Group's score of 0.00 indicating that Joint is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Joint	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 76.9% of Joint shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by insiders. Comparatively, 30.2% of Joint shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SBC Medical Group has a net margin of 24.09% compared to Joint's net margin of 6.49%. SBC Medical Group's return on equity of 15.90% beat Joint's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	24.09%	15.90%	11.61%
Joint	6.49%	12.02%	3.47%

SBC Medical Group presently has a consensus target price of $8.50, indicating a potential upside of 172.87%. Given SBC Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe SBC Medical Group is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

SBC Medical Group has higher revenue and earnings than Joint. SBC Medical Group is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61M	1.84	$50.99M	$0.39	7.99
Joint	$58.55M	2.07	$2.91M	$0.27	31.48

Summary

SBC Medical Group beats Joint on 10 of the 16 factors compared between the two stocks.

How does Joint compare to InfuSystem?

InfuSystem (NYSE:INFU) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Joint has lower revenue, but higher earnings than InfuSystem. InfuSystem is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$143.34M	1.75	$870K	$0.41	30.31
Joint	$58.55M	2.07	$2.91M	$0.27	31.48

Joint has a net margin of 6.49% compared to InfuSystem's net margin of 1.12%. Joint's return on equity of 12.02% beat InfuSystem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Joint	6.49%	12.02%	3.47%

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 10.8% of InfuSystem shares are held by insiders. Comparatively, 30.2% of Joint shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

InfuSystem has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Joint has a beta of 1.1, indicating that its share price is 10% more volatile than the broader market.

InfuSystem currently has a consensus price target of $16.67, suggesting a potential upside of 34.09%. Given InfuSystem's stronger consensus rating and higher possible upside, research analysts clearly believe InfuSystem is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Joint had 2 more articles in the media than InfuSystem. MarketBeat recorded 7 mentions for Joint and 5 mentions for InfuSystem. InfuSystem's average media sentiment score of 0.67 beat Joint's score of 0.66 indicating that InfuSystem is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Joint	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

InfuSystem and Joint tied by winning 8 of the 16 factors compared between the two stocks.

Get Joint News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JYNT vs. The Competition

Export

Metric	Joint	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$121.17M	$9.91B	$7.05B	$12.94B
Dividend Yield	N/A	2.55%	2.58%	10.06%
P/E Ratio	31.48	25.21	268.69	24.87
Price / Sales	2.07	4.81	586.52	95.58
Price / Cash	85.64	25.58	28.89	37.42
Price / Book	8.42	5.33	11.29	6.44
Net Income	$2.91M	$307.72M	$3.44B	$347.05M
7 Day Performance	2.66%	0.33%	2.23%	1.00%
1 Month Performance	-5.45%	0.05%	-0.21%	-0.59%
1 Year Performance	-21.30%	22.07%	75.56%	22.26%

Joint Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JYNT Joint	3.0819 of 5 stars	$8.50 -1.5%	N/A	-19.6%	$121.17M	$58.55M	31.48	320	Earnings Report Analyst Upgrade
CCRN Cross Country Healthcare	1.6312 of 5 stars	$13.25 flat	$12.05 -9.1%	N/A	$428.05M	$1.00B	N/A	6,784
VMD Viemed Healthcare	2.806 of 5 stars	$9.84 -15.8%	N/A	+31.3%	$377.27M	$270.28M	26.59	1,382	High Trading Volume
TACO Berto Acquisition	N/A	$10.44 +0.1%	N/A	+0.5%	$340.55M	N/A	N/A	7,892	Positive News
SBC SBC Medical Group	2.3525 of 5 stars	$3.16 flat	$8.50 +169.0%	-30.0%	$324.15M	$173.61M	8.10	N/A	Positive News Upcoming Earnings Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JYNT) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Joint (JYNT) Competitors

JYNT vs. CCRN, VMD, TACO, SBC, and INFU

How does Joint compare to Cross Country Healthcare?

Summary

How does Joint compare to Viemed Healthcare?

Summary

How does Joint compare to Berto Acquisition?

Summary

How does Joint compare to SBC Medical Group?

Summary

How does Joint compare to InfuSystem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JYNT vs. The Competition

Joint Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Joint (JYNT) Competitors

JYNT vs. CCRN, VMD, TACO, SBC, and INFU

How does Joint compare to Cross Country Healthcare?

Which has more risk & volatility, JYNT or CCRN?

Do institutionals and insiders have more ownership in JYNT or CCRN?

Which has stronger earnings & valuation, JYNT or CCRN?

Does the media favor JYNT or CCRN?

Do analysts recommend JYNT or CCRN?

Is JYNT or CCRN more profitable?

Summary

How does Joint compare to Viemed Healthcare?

Does the media prefer JYNT or VMD?

Do analysts prefer JYNT or VMD?

Do insiders and institutionals have more ownership in JYNT or VMD?

Which has more volatility and risk, JYNT or VMD?

Is JYNT or VMD more profitable?

Which has better valuation & earnings, JYNT or VMD?

Summary

How does Joint compare to Berto Acquisition?

Do analysts rate TACO or JYNT?

Which has more risk and volatility, TACO or JYNT?

Does the media favor TACO or JYNT?

Which has preferable valuation and earnings, TACO or JYNT?

Do insiders and institutionals believe in TACO or JYNT?

Is TACO or JYNT more profitable?

Summary

How does Joint compare to SBC Medical Group?

Which has more volatility and risk, SBC or JYNT?

Does the media prefer SBC or JYNT?

Do insiders & institutionals have more ownership in SBC or JYNT?

Is SBC or JYNT more profitable?

Do analysts prefer SBC or JYNT?

Which has higher earnings and valuation, SBC or JYNT?

Summary

How does Joint compare to InfuSystem?

Which has higher earnings & valuation, INFU or JYNT?

Is INFU or JYNT more profitable?

Do institutionals & insiders have more ownership in INFU or JYNT?

Which has more risk and volatility, INFU or JYNT?

Do analysts prefer INFU or JYNT?

Does the media prefer INFU or JYNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JYNT vs. The Competition

Joint Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools